Suppr超能文献

需要透析和肾移植的成人肠道移植受者的结局

Outcomes of Adult Intestinal Transplant Recipients Requiring Dialysis and Renal Transplantation.

作者信息

Puttarajappa Chethan M, Hariharan Sundaram, Humar Abhinav, Paliwal Yuvika, Gao Xiaotian, Cruz Ruy J, Ganoza Armando J, Landsittel Douglas, Bhattarai Manoj, Sogawa Hiroshi

机构信息

Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA.

Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA.

出版信息

Transplant Direct. 2018 Jul 20;4(8):e377. doi: 10.1097/TXD.0000000000000815. eCollection 2018 Aug.

Abstract

BACKGROUND

Data on dialysis and renal transplantation (RT) after intestinal transplantation (IT) are sparse. Whether changes in immunosuppression and surgical techniques have modified these outcomes is unknown.

METHODS

Two hundred eighty-eight adult intestinal transplants performed between 1990 and 2014 at the University of Pittsburgh were analyzed for incidence, risk factors and outcomes after dialysis and RT. Cohort was divided into 3 eras based on immunosuppression and surgical technique (1990-1994, 1995-2001, and 2001-2014). Receiving RT, or dialysis for 90 days or longer was considered as end-stage renal disease (ESRD).

RESULTS

During a median follow-up of 5.7 years, 71 (24.7%) patients required dialysis, 38 (13.2%) required long-term dialysis and 17 (6%) received RT after IT. One-, 3-, and 5-year ESRD risk was 2%, 7%, and 14%, respectively. No significant era-based differences were noted. Higher baseline creatinine (hazard ratio [HR], 3.40 per unit increase, < 0.01) and use of liver containing grafts (HR, 2.01; = 0.04) had an increased ESRD risk. Median patient survival after dialysis initiation was 6 months, with a 3-year survival of 21%. Any dialysis (HR, 12.74; 95% CI 8.46-19.20; < 0.01) and ESRD (HR, 9.53; 95% CI, 5.87-15.49; < 0.01) had higher mortality after adjusting for covariates. For renal after IT, 1- and 3-year kidney and patient survivals were 70% and 49%, respectively. All graft losses were from death with a functioning graft, primarily related to infectious complications (55%).

CONCLUSIONS

In intestinal transplant recipients, renal failure requiring dialysis or RT is high and is associated with increased mortality. Additionally, the outcomes for kidney after IT are suboptimal due to death with a functioning graft.

摘要

背景

肠道移植(IT)后透析和肾移植(RT)的数据稀少。免疫抑制和手术技术的变化是否改变了这些结果尚不清楚。

方法

分析了1990年至2014年在匹兹堡大学进行的288例成人肠道移植患者透析和肾移植后的发生率、危险因素及结果。根据免疫抑制和手术技术将队列分为3个时期(1990 - 1994年、1995 - 2001年和2001 - 2014年)。接受肾移植或透析90天及以上被视为终末期肾病(ESRD)。

结果

在中位随访5.7年期间,71例(24.7%)患者需要透析,38例(13.2%)需要长期透析,17例(6%)在肠道移植后接受了肾移植。1年、3年和5年的ESRD风险分别为2%、7%和14%。未观察到基于时期的显著差异。基线肌酐水平较高(风险比[HR],每单位增加3.40,<0.01)和使用含肝移植物(HR,2.01;=0.04)会增加ESRD风险。开始透析后的中位患者生存期为6个月,3年生存率为21%。调整协变量后,任何透析(HR,12.74;95%可信区间8.46 - 19.20;<0.01)和ESRD(HR,9.53;95%可信区间5.87 - 15.49;<0.01)的死亡率更高。对于肠道移植后的肾脏,1年和3年的肾脏及患者生存率分别为70%和49%。所有移植物丢失均因移植物功能正常时患者死亡,主要与感染并发症有关(55%)。

结论

在肠道移植受者中,需要透析或肾移植的肾衰竭发生率很高,且与死亡率增加相关。此外,由于移植物功能正常时患者死亡,肠道移植后肾脏的结果并不理想。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d8f/6092176/6859e1701a3d/txd-4-e377-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验